Astera Labs, Inc. $ALAB Shares Sold by Arizona State Retirement System

Arizona State Retirement System cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 6.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,454 shares of the company’s stock after selling 2,523 shares during the quarter. Arizona State Retirement System’s holdings in Astera Labs were worth $6,064,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after acquiring an additional 1,693,918 shares during the last quarter. Amundi raised its stake in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC bought a new position in shares of Astera Labs during the third quarter worth about $209,599,000. BNP Paribas Financial Markets lifted its position in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after purchasing an additional 960,899 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Astera Labs in the third quarter worth about $131,539,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 10,188 shares of the business’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the completion of the transaction, the chief executive officer owned 4,069,134 shares of the company’s stock, valued at approximately $713,929,560.30. The trade was a 0.25% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of the business’s stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $175.12, for a total transaction of $657,925.84. Following the transaction, the director directly owned 67,144 shares of the company’s stock, valued at $11,758,257.28. The trade was a 5.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. 12.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $250.00 price objective on shares of Astera Labs in a report on Tuesday, April 21st. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. UBS Group initiated coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target for the company. Citigroup assumed coverage on Astera Labs in a research report on Thursday, April 2nd. They set a “buy” rating and a $200.00 price target on the stock. Finally, Loop Capital initiated coverage on Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective on the stock. Fifteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $199.74.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Wall Street and institutions backing the story — multiple buy/outperform ratings and a cluster of price targets (median ~$215) plus large Q4 2025 institutional purchases (e.g., BlackRock) support bullish positioning and provide demand for the stock. Astera Labs gains as investors refocus on AI interconnect demand and upcoming earnings catalyst
• Positive Sentiment: AI-infrastructure narrative and upcoming earnings act as a near-term catalyst — investors are repositioning ahead of early‑May Q1 results and continue to value Astera’s role in solving data‑center connectivity bottlenecks (Aries/Scorpio product relevance). Cramer Names ‘The Stocks That Got Away’
• Positive Sentiment: Favorable industry coverage highlights the company’s strategic positioning in AI data centers, reinforcing growth expectations. This thematic coverage can drive momentum among growth and thematic funds. Astera Labs: The Tollbooth for AI’s Traffic Jam
• Neutral Sentiment: UBS initiated coverage with a Neutral rating — this provides liquidity and analyst visibility but is not an explicit endorsement; UBS’s target (~$180) is below the median of recent targets, which may cap upside for some investors. Astera Labs (NASDAQ:ALAB) Research Coverage Started at UBS Group
• Neutral Sentiment: Coverage pieces highlighting insider ownership and growth metrics signal interest from investors who track insider alignment, but these lists are informational rather than direct catalysts. April 2026’s High Insider Ownership Growth Leaders
• Negative Sentiment: Significant insider selling — CEO Jitendra Mohan and other senior insiders have sold large blocks in April under 10b5-1 plans (reports show tens of millions in proceeds). Heavy insider liquidation can pressure sentiment and raise short‑term selling risk despite the company’s growth story. This AI Stock Has Tripled Since Its IPO. Its CEO Just Cashed In. Insider Selling: Astera Labs (NASDAQ:ALAB) CEO Sells $56,064,793.02 in Stock

Astera Labs Stock Performance

NASDAQ:ALAB opened at $212.84 on Monday. The firm has a market capitalization of $36.46 billion, a PE ratio of 174.46, a price-to-earnings-growth ratio of 4.19 and a beta of 1.78. The stock has a 50 day moving average of $133.87 and a 200-day moving average of $153.15. Astera Labs, Inc. has a 52 week low of $62.31 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s revenue was up 91.8% on a year-over-year basis. During the same quarter last year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.